Clal Insurance’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.5M | Buy |
86,570
+515
| +0.6% | +$401K | 0.66% | 39 |
|
|
2025
Q1 | $71.1M | Sell |
86,055
-3,649
| -4% | -$3.01M | 0.73% | 35 |
|
|
2024
Q4 | $69.3M | Buy |
89,704
+4,904
| +6% | +$3.79M | 0.62% | 36 |
|
|
2024
Q3 | $75.1M | Buy |
84,800
+13,200
| +18% | +$11.7M | 0.66% | 39 |
|
|
2024
Q2 | $64.8M | Sell |
71,600
-1,700
| -2% | -$1.54M | 0.68% | 36 |
|
|
2024
Q1 | $57M | Sell |
73,300
-1,200
| -2% | -$934K | 0.64% | 40 |
|
|
2023
Q4 | $43.4M | Buy |
74,500
+73,500
| +7,350% | +$42.8M | 0.57% | 47 |
|
|
2023
Q3 | $537K | Sell |
1,000
-1,000
| -50% | -$537K | 0.01% | 105 |
|
|
2023
Q2 | $938K | Sell |
2,000
-500
| -20% | -$235K | 0.01% | 111 |
|
|
2023
Q1 | $859K | Buy |
+2,500
| New | +$859K | 0.01% | 117 |
|